These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. Furmanski P; Longley C Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012 [TBL] [Abstract][Full Text] [Related]
3. MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T. Place DA; Faustino PJ; Berghmans KK; van Zijl PC; Chesnick AS; Cohen JS Magn Reson Imaging; 1992; 10(6):919-28. PubMed ID: 1461089 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors. Fiel RJ; Musser DA; Mark EH; Mazurchuk R; Alletto JJ Magn Reson Imaging; 1990; 8(3):255-9. PubMed ID: 2366638 [TBL] [Abstract][Full Text] [Related]
5. Metalloporphyrins as contrast agents for tumors in magnetic resonance imaging. Place DA; Faustino PJ; van Zijl PC; Chesnick A; Cohen JS Invest Radiol; 1990 Sep; 25 Suppl 1():S69-70. PubMed ID: 2283262 [No Abstract] [Full Text] [Related]
6. Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice. Patronas NJ; Cohen JS; Knop RH; Dwyer AJ; Colcher D; Lundy J; Mornex F; Hambright P; Sohn M; Myers CE Cancer Treat Rep; 1986 Mar; 70(3):391-5. PubMed ID: 3955550 [TBL] [Abstract][Full Text] [Related]
7. Metalloporphyrin magnetic resonance contrast agents. Feasibility of tumor-specific magnetic resonance imaging. van Zijl PC; Place DA; Cohen JS; Faustino PJ; Lyon RC; Patronas NJ Acta Radiol Suppl; 1990; 374():75-9. PubMed ID: 1966973 [TBL] [Abstract][Full Text] [Related]
8. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats. Schmiedl UP; Nelson JA; Starr FL; Schmidt R Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554 [TBL] [Abstract][Full Text] [Related]
9. [Specific and non-specific contrast media for MRI of tumors. Experimental study of human breast carcinoma]. Revel D; Ogan M; Paajanen H; Grodd W; Couet W; Rosenau W; Brasch RC J Radiol; 1989 Feb; 70(2):115-21. PubMed ID: 2715972 [TBL] [Abstract][Full Text] [Related]
10. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. Ogan MD; Revel D; Brasch RC Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177 [TBL] [Abstract][Full Text] [Related]
11. Manganese(iii)-chelated porphyrin microbubbles for enhanced ultrasound/MR bimodal tumor imaging through ultrasound-mediated micro-to-nano conversion. Chen M; Liang X; Dai Z Nanoscale; 2019 May; 11(21):10178-10182. PubMed ID: 31111845 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis and cell growth arrest in A375 human melanoma cells by diorganotin(IV) and triorganotin(IV) complexes of [meso-Tetra(4-sulfonatophenyl)porphine] manganese(III)chloride. Costa MA; Zito F; Emma MR; Pellerito L; Fiore T; Pellerito C; Barbieri G Int J Oncol; 2011 Mar; 38(3):693-700. PubMed ID: 21206968 [TBL] [Abstract][Full Text] [Related]
13. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice. Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324 [TBL] [Abstract][Full Text] [Related]
14. [Mn-TPPS4; a potential MRI contrast agent for localizing the normal aortic wall in rabbits]. Kim SW; Kozuka T Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):192-4. PubMed ID: 2362799 [TBL] [Abstract][Full Text] [Related]
15. Use of metalloporphyrins in diagnostic imaging. Fawwaz R; Bohdiewicz P; Lavallee D; Wang T; Oluwole S; Newhouse J; Alderson P Int J Rad Appl Instrum B; 1990; 17(1):65-72. PubMed ID: 2407694 [No Abstract] [Full Text] [Related]
16. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging. Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556 [TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging. Young SW; Sidhu MK; Qing F; Muller HH; Neuder M; Zanassi G; Mody TD; Hemmi G; Dow W; Mutch JD Invest Radiol; 1994 Mar; 29(3):330-8. PubMed ID: 8175308 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro and in vivo evaluation of manganese(III) porphyrin-dextran as a novel MRI contrast agent. Zhang Z; He R; Yan K; Guo QN; Lu YG; Wang XX; Lei H; Li ZY Bioorg Med Chem Lett; 2009 Dec; 19(23):6675-8. PubMed ID: 19850475 [TBL] [Abstract][Full Text] [Related]
19. Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model. Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Sugiyama M; Takeda H; Saga T; Nakajima S; Sakata I Magn Reson Med; 2002 Mar; 47(3):549-53. PubMed ID: 11870842 [TBL] [Abstract][Full Text] [Related]